Virus cocktail targets superbug pneumonia in first human test
Disease control
Not yet recruiting
This early-stage trial tests MP101, a mix of two viruses that attack bacteria (phages), in 18 adults with Pseudomonas aeruginosa pneumonia. Participants receive a single dose of MP101 or a placebo alongside standard antibiotics. The main goal is to check safety and how the body h…
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC